Clinical Trial Update: Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial evaluating safety and efficacy of allogeneic adoptive immune therapy for immune reconstitution in chronic HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Immune Reconstitution
• Human Immunodeficiency Virus

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Human Immunodeficiency Virus, Disorder of Immune Reconstitution | Phase 1, Phase 2 | Status: UNKNOWN